Expression of the inducible nitric oxide synthase gene in diaphragm and skeletal muscle. J. Appl. Physiol. 81(6): 2415-2420, 1996.-Nitric oxide (NO) is a pluripotent molecule that can be secreted by skeletal muscle through the activity of the neuronal constitutive isoform of NO synthase. To determine whether skeletal muscle and diaphragm might also express the macrophage-inducible form of NO synthase (iNOS) during provocative states, we examined tissue from mice at serial times after intravenous administration of Escherichia coli endotoxin. In these studies, iNOS mRNA was strongly expressed in the diaphragm and skeletal muscle of mice 4 h after intravenous endotoxin and was significantly diminished by 8 h after challenge. Induction of iNOS mRNA was followed by expression of iNOS immunoreactive protein on Western immunoblots. Increased iNOS activity was demonstrated by conversion of arginine to citrulline. Immunochemical analysis of diaphragmatic explants exposed to endotoxin in vitro revealed specific iNOS staining in myocytes, in addition to macrophages and endothelium. These results may be important in understanding the pathogenesis of respiratory pump failure during septic shock, as well as skeletal muscle injury during inflammation or metabolic stress. endotoxin; cytokines; septic shock NITRIC OXIDE (NO) is a multifunctional molecule that participates in regulation of vasomotor tone, microbiological defense, neural transmission, and intracellular signal transduction (28). NO is produced during the oxidation of arginine to citrulline by constitutive and inducible isoforms of the enzyme NO synthase (NOS) (30, 31). Recently, Balon and Nadler (3) demonstrated NO release from incubated normal rat extensor digitorum longus muscle preparations but did not definitively determine whether NO was secreted by skeletal myocytes or other cells in their preparations, e.g., endothelial cells (37). Simultaneously with these observations, Kobzik and co-workers (24) documented the presence of the neuronal constitutive isoform of NOS (ncNOS) in rat skeletal muscle by immunocytochemistry. These results substantiated earlier work by Nakane et al. (29), who demonstrated the presence of ncNOS mRNA in human skeletal muscle. These data have fueled speculations that NO may play an important role in the physiology of skeletal muscle contraction or metabolism (38).
NITRIC OXIDE (NO) is a multifunctional molecule that participates in regulation of vasomotor tone, microbiological defense, neural transmission, and intracellular signal transduction (28) . NO is produced during the oxidation of arginine to citrulline by constitutive and inducible isoforms of the enzyme NO synthase (NOS) (30, 31) . Recently, Balon and Nadler (3) demonstrated NO release from incubated normal rat extensor digitorum longus muscle preparations but did not definitively determine whether NO was secreted by skeletal myocytes or other cells in their preparations, e.g., endothelial cells (37) . Simultaneously with these observations, Kobzik and co-workers (24) documented the presence of the neuronal constitutive isoform of NOS (ncNOS) in rat skeletal muscle by immunocytochemistry. These results substantiated earlier work by Nakane et al. (29) , who demonstrated the presence of ncNOS mRNA in human skeletal muscle. These data have fueled speculations that NO may play an important role in the physiology of skeletal muscle contraction or metabolism (38) .
Inducible NOS (iNOS) has also been demonstrated in a number of cell types, including macrophages, hepatocytes, vascular smooth muscle cells, epithelial cells, and endothelial cells (18, 26, 27, 35) . Recently, we have described the induction of iNOS in skeletal muscle myotubes and myoblasts of the C2C12 lineage in vitro (41) . In C2C12 cells, iNOS was induced by combinations of cytokines that included interferon-g and yielded biosynthesis of NO in quantities equivalent to these produced by macrophages under similar conditions.
It currently remains unknown whether the iNOS gene is also expressed by skeletal muscle in vivo. Given recent data suggesting the importance of NO produced by ncNOS in normal skeletal muscle, we determined whether iNOS might be induced in skeletal muscle and diaphragm during inflammatory conditions in vivo. Because NO has been shown to depress skeletal muscle contractility in vitro (24) , expression of iNOS by skeletal muscle during endotoxemia may elucidate the pathogensis of respiratory pump failure and muscle catabolism during septic shock.
METHODS

Animals.
Six-to eight-week-old male C3H/HeN mice (Sasco) were housed in a thermal-and light-controlled animal facility and allowed free access to chow and water. Experimental and control animals were injected intravenously through the tail vein with either 50 µg of Escherichia coli O111:B4 lipopolysaccharide (LPS; Sigma Chemical) or an equivalent volume of sterile normal saline. Animals were monitored by using a rodent distress assessment that monitored body weight, appearance, clinical signs, and unprovoked behavior as measures of distress. Animals were killed at the indicated times after CO 2 narcosis followed by cervical dislocation.
RNA purification and Northern blots. Tissues were carefully excised from the killed animals and rinsed thoroughly in normal saline. Samples were obtained from the cardiac ventricles (atria excluded), each hemidiaphragm, and quadriceps skeletal muscles. Total RNA was purified by a modification of the method of Chomczynski and Sacchi (11) by using RNAzol B (Biotecz Labs, Houston, TX). The RNA was quantitated by absorbance at 260 nm, and 10 µg of total RNA were resolved on a 1.2% agarose gel as previously described. The iNOS probe consisted of a 765-bp fragment complementary to the 58 end of the murine macrophage iNOS cDNA (41) . Experiments were independently repeated seven times, with groups as indicated in RESULTS.
Western immunoblots. Tissues were immediately harvested from the killed animals. An equivalent amount of tissue (depending on the tissue examined, between 50 and 150 mg) was homogenized in 800 µl of ice-cold grind buffer containing 50 mM tris(hydroxymethyl)aminomethane (Tris), pH 7.4, 1 mM EDTA, 0.1 mM dithiothreitol (DTT), 4 µM bestatin, 1 mM N a -p-tosyl-L-lysine chromomethyl ketone (TLCK), 1 mM phenylmethylsulfonyl fluoride (PMSF), 20 mM 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), and 10 µg/ml each of leupeptin, pepstatin A, and aprotonin. The sample was then centrifuged for 10 min at 10,000 g at 4°C, and supernatant was collected. To this supernatant were then added 50 µl of preswollen 28-58 ADP-sepharose-4B (Pharmacia), which was then gently rocked for 1 h at 4°C. The preswollen 28-58ADP-sepharose-4B was composed of one-third volume 28-5-sepharose-4B and twothirds volume grind buffer. After an additional centrifugation and after discarding of the supernate, 100 µl of an elution buffer consisting of 13 homogenization buffer, 10 mM NADP, and 10% vol/vol glycerol were added to the conjugated ADPsepharose. After incubation for 15 min on ice, supernatant was removed after centrifugation. Forty microliters of this supernatant were added to an equal volume of gel-loading buffer (50 mM Tris, pH 6.8, 100 mM DTT, 2% sodium dodecyl sulfate, 0.1% bromphenol blue, and 10% glycerol), boiled for 10 min at 100°C, resolved on a 6% polyacrylamide gel, then transferred to a nitrocellulose membrane. The membrane was blocked overnight at 4°C in 5% dried milk dissolved in Tris-buffered saline-Tween 20 (TBS-T) (20 mM Tris, pH 7.6, 137 mM NaCl, 0.1% Tween 20). The membrane was then washed in TBS-T and incubated for 1 h with a monoclonal anti-mouse iNOS antibody (Transduction Laboratories) used at 1:500 dilution. After two additional washes in TBS-T, the membrane was incubated for 1 h at room temperature with a 1:8,000 dilution of sheep anti-mouse immunoglobulin G horseradish peroxidase-linked antibody (Amersham). After an additional wash in TBS-T, the membrane was exposed to the mixture of luminol plus hydrogen peroxide under alkaline conditions, and the strength of the resulting chemiluminescent reaction was registered by autoradiography. Experiments were done independently three times, with groups as indicated in RESULTS. iNOS activity. iNOS activity was determined by measuring the conversion of Immunochemistry. Explants from normal mouse diaphragm (,3 3 3 mm) were incubated for 24 h in Dulbecco's modified Eagle medium (Sigma Chemical) supplemented with 5% heat-inactivated fetal bovine serum (GIBCO BRL) and 4% penicillin-streptomycin solution (GIBCO BRL). Cultures were maintained in a humidified atmosphere of 5% CO 2 in an incubator at 37°C. Explants were either exposed or not exposed to 1 µg/ml LPS (E. coli O111:B4, Sigma Chemical) for 24 h. After incubation, tissue was fixed in 100% ethanol and routinely processed for light microscopy and embedded in paraffin. Four-micrometer-thick sections were deparaffinized and incubated overnight at room temperature with a 1:50 dilution of mouse monoclonal anti-iNOS antiserum (Transduction Labs, Lexington, KY). Immunoreactivity was detected by using streptavidin-biotin methodology with commercially available kits, according to the manufacturer's specifications (Cell Marque, Austin, TX). Negative controls, consisting of sections incubated in buffer alone, were run concurrently.
Statistical analysis. Values for mRNA densitometry and [ 3 H]arginine are expressed as means 6 SE. The statistical significance was determined by one-way analysis of variance with Bonferroni correction. Statistical significance was set at P , 0.05.
RESULTS
Animals that had received intravenous endotoxin showed moderate distress scores based on anorexia, piloerection, lethargy, and 3% weight loss. These animals demonstrated the induction of iNOS mRNA in diaphragm and skeletal muscle, which peaked at 4 h and was significantly diminished by 8 h after challenge. Levels of iNOS mRNA in the diaphragm were comparable to those induced in the myocardium, whereas the levels induced in skeletal muscle were higher compared with controls (Fig. 1) . Densitometric analysis (Fig. 1 ) demonstrated a fivefold increase in the diaphragm and a sevenfold increase in the quadriceps skeletal muscle, compared with control levels. iNOS mRNA was not demonstrated in sheep pulmonary artery endothelium. Because iNOS gene expression is significantly regu- Fig. 1 . Expression of inducible nitric oxide synthase (iNOS) mRNA in myocardium, diaphragm, and quadriceps skeletal muscle. Organs were removed at indicated times after intravenous injection of 50 µg lipopolysaccharides (LPS). Controls were RAW macrophages stimulated by LPS (1 ng/ml), interferon-g (100 IU/ml), tumor necrosis factor-a (1 ng/ml), interleukin-1 (50 IU/ml), and pulmonary artery endothelium. Densitometric analysis was performed on all blots with results as indicated above; n 5 7 samples. * Significant difference at P , 0.05. (Fig. 2) demonstrated nondetectable or only minimally detectable iNOS immunoreactive bands under control conditions; however, after endotoxin challenge, the iNOS bands, as detected by monoclonal antibody to mouse macrophage iNOS, were significantly increased at both 8 and 12 h after challenge, in both the diaphragm and skeletal muscle as well as in the heart. We found that iNOS protein was present, and, in addition, that iNOS activity (Fig. 2) was also present and increased after LPS administration. The conversion of arginine to citrulline not only documented the presence of iNOS activity but also quantified its activity on a microgram of protein basis. This quantification is important, as it is difficult to quantitate the protein used in the ADP-sepharose extractbased Western blots. The ADP-sepharose binds selectively to iNOS to enrich the iNOS content, which results in specimens that are semiqualitative. Activity expressed as units per microgram of protein was significantly increased from control levels at 8 and 12 h after LPS administration. iNOS activity levels were over fivefold higher in both the diaphragm and skeletal muscle at 8 h and remained elevated above control levels at 12 h post LPS administration. iNOS activity was fully inhibited by the addition of N-nitro-Larginine methyl ester in all tissue types (results not shown).
Although it is unlikely that endothelial cells or infiltrating macrophages could account for the observed significant increase in iNOS mRNA and immunoreactive protein, we next sought to localize iNOS immunoreactive protein to the myocytes themselves. Sections of diaphragm from LPS-treated mice stained immunochemically for iNOS showed moderate immunoreactivity within the endothelium of blood vessels within the muscle. Rare isolated intermuscular cells, morphologically consistent with macrophages, were strongly immunoreactive (arrow). Muscle fibers were negative (Fig. 3A) . The diaphragm from control animals showed less endothelial reactivity and no evidence of macrophage or myocyte iNOS production (Fig.  3B) . Because the lack of myocyte immunostaining could be explained by the insensitivity of immunochemistry compared with Northern and Western analyses, we attempted to increase the levels of iNOS expression by incubating diaphragm explants in vitro with or without the presence of bacterial LPS. Microscopic sections of the diaphragm explants showed cytoplasmic immunoreactivity for iNOS within myocytes. Low levels of iNOS expression were present in control explants incubated for 24 h (Fig. 3D ) compared with nonincubated explants (Fig. 3E) . iNOS immunoreactivity (brown stain) was significantly increased in myocytes from explants exposed to LPS for 24 h (Fig. 3C ).
DISCUSSION
We have previously reported the induction and expression of the macrophage-type iNOS gene in C2C12 skeletal myoblasts and myotubes in vitro (41) . To our knowledge, the experiments reported here are the first to demonstrate induction of iNOS mRNA, iNOS protein, and iNOS activity in skeletal muscle and diaphragm in vivo. Induction of immunoreactive iNOS protein was demonstrated in diaphragm in vitro, although not in vivo. This is consistent with previous iNOS immunochemical findings. Despite the fact that several investigators have convincingly demonstrated NO production from cardiac myocytes (9), cardiac myocytes have not been immunoreactive for iNOS. Buttery et al. (9) immunostained for iNOS protein in LPSexposed rats and were unable to demonstrate iNOS staining in cardiac myocytes, although staining of macrophages was noted. Yet, Balligand et al. (2) demonstrated NO release from single cytokine-stimulated rat cardiac myocytes. The lack of iNOS immunostaining in the cardiac myocytes was thought to be secondary to lack of sensitivity of the immunochemical technique to lower levels of iNOS protein.
The precise role of iNOS expression in striated muscle during endotoxemia or other provocative states is yet unknown; nonetheless, it is possible that iNOS expression may be detrimental and lead to respiratory muscle dysfunction; alternately, iNOS expression may be adaptive in that production of NO may lead to enhanced oxygen and substrate delivery to vital tissues during prolonged periods of disease and/or physiologi- cal stress. Thus, since it not known whether increased NO production plays a pathophysiological, compensatory, or incidental role in septic shock, the relevance of these findings to human septic shock is not yet determined.
During septic shock of gram-negative and grampositive etiologies, diaphragmatic function is abnormal. In a canine endotoxic shock model, Hussain et al. (21) demonstrated that death resulted not from cardiac failure but from respiratory compromise and, ultimately, respiratory failure. These and other investigators have since determined that sepsis causes diaphragmatic dysfunction evidenced by diminished diaphragmatic contractility and reduced endurance (5, 20) . Dysfunction of the diaphragm can be induced in vitro by LPS-activated monocyte supernatant but is not the result of a direct and immediate effect of tumor necrosis factor-a or endotoxin (12, 40) . It is possible that NO produced by the diaphragm, induced by endotoxin and cytokines, may account for the diaphragmatic dysfunction witnessed during sepsis. The recent report by Kobzik et al. (24) documented that production of NO by diaphragm via ncNOS diminished contractility, whereas inhibitors of NOS activity and guanosine 38,58-cyclic monophosphate augmented contractile function. Precedent for a contractility depressant effect of NO is also found in the literature investigating sepsisinduced myocardial dysfunction. Although these data remain controversial (39) , several investigators have demonstrated that NO causes contractile dysfunction in both cardiac myocytes and papillary muscles (1, 7, 8, 15, 16, 23) . In addition, intracoronary infusion of the NO donor nitroprusside into nonseptic humans resulted in reduced left ventricular pressure development and a left ventricular relaxation hastening effect (32) .
Detrimental effects of NO on muscle function could be mediated directly through the stimulation of soluble guanylate cyclase, indirectly through guanosine 38,58-cyclic monophosphate-dependent protein kinases, or by interactions of NO with transcription factors (25, 28) . NO has also been demonstrated to reversibly inhibit cytochrome c in skeletal muscle mitochondrial respiration. This inhibition could decrease ATP production, ultimately resulting in respiratory muscle dysfunction (12) . Additionally, it is known that skeletal muscles produce reactive oxygen radicals during stress (33, 34) ; reactive oxygen radicals could combine with NO to form peroxynitrite and, thereby, lead to cell injury or death (4, 17) . Consistent with this speculation is a recent report that documented skeletal muscle edema and fiber necrosis during a porcine model of septic shock (19) .
Alternately, the induction of NOS in diaphragm and skeletal muscle may be adaptive during certain conditions in that prolonged exertional or metabolic stress would increase NO production and thereby improve organ blood flow. This may be particularly important during endotoxic shock, during which time diaphragmatic oxygen extraction is impaired, and a pathological oxygen supply-demand relationship may exist (22) . In regard to nondiaphragm skeletal muscle, a number of cytokines, including interleukin-1, tumor necrosis factor-a, and interferon-g, are known to be elevated in skeletal muscle and/or in serum after prolonged vigorous exercise (6, 10, 14) . NO of skeletal muscle origin may also function to enhance local oxygen and substrate delivery and, thereby, be adaptive during such metabolic or exertional stresses.
In 1991, Salter and colleagues (36) surveyed biochemical evidence of NOS activity in multiple tissues from three species. These investigators reported the presence of calcium-independent NOS activity in the rat diaphragm, but not in rat, rabbit, or guinea pig skeletal muscle, 6 h after intraperitoneal endotoxin challenge. The present data confirm the inferences of Salter and co-workers that calcium-independent iNOS is induced in the diaphragm and extend their observations to include nonrespiratory skeletal muscle. The addition of EGTA as a calcium chelator to our assay ensured measurement of calcium-independent iNOS activity, since brain cell NOS and ecNOS are calcium-dependent enzymes. There are several possible explanations for the detection of iNOS in our system and not in that of Salter et al. First, our experiments were done on mice, and therefore a species-specific difference may account for the discrepancy. Which species most closely approximates human iNOS responses is yet unknown. In addition, the current methodology was designed to directly detect the iNOS gene products (both mRNA and protein), in contrast to detection of citrulline as indirect evidence of NOS induction and/or activity. Alternatively, although we were able to demonstrate the induction of iNOS after both intraperitoneal and intravenous endotoxin administration, induction of iNOS in nondiaphragmatic skeletal muscle was much greater with intravenous endotoxin administration, even when the intravenous doses of LPS were 20% of those administered intraperitoneally (data not shown). We demonstrated an increase in iNOS protein production and activity. It is also possible that NOS cofactors levels, such as tetrahydrobiopterin, may be affected by LPS, which may also influence iNOS activity.
The present study supports the concept that NO may be produced by numerous cell types within tissues of diverse origins. The net beneficial or detrimental effects of this pluripotent molecule may depend on the particular circumstances of its production and the physiological state of the organism in which it is produced.
